Negative Regulation of BMP/Smad Signaling by Tob in Osteoblasts

Slides:



Advertisements
Similar presentations
Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma  Ya-Wei Qiang, Bart.
Advertisements

Volume 56, Issue 5, Pages (November 1999)
Volume 93, Pages 1-11 (December 2016)
UVB Increases Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression1  Christoph Marschall, Toshiko Nobutoh, Evelyn Braungart, Kathrin Douwes,
Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia by Hironori.
Volume 11, Issue 6, Pages (June 2003)
A Novel Cofactor for p300 that Regulates the p53 Response
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Volume 121, Issue 1, Pages (April 2005)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
MafB negatively regulates RANKL-mediated osteoclast differentiation
Regulation of expression of murine transferrin receptor 2
M. Wang, H. Jin, D. Tang, S. Huang, M.J. Zuscik, D. Chen 
Volume 9, Issue 1, Pages (January 2002)
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Volume 7, Issue 6, Pages (December 1997)
M. Wang, H. Jin, D. Tang, S. Huang, M.J. Zuscik, D. Chen 
Histone deacetylase 3 associates with and represses the transcription factor GATA-2 by Yukiyasu Ozawa, Masayuki Towatari, Shinobu Tsuzuki, Fumihiko Hayakawa,
ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes
Volume 15, Issue 1, Pages (July 2001)
Volume 16, Issue 6, Pages (December 2004)
Volume 56, Issue 5, Pages (November 1999)
Volume 11, Issue 4, Pages (October 1999)
Volume 8, Issue 2, Pages (August 2001)
Volume 15, Issue 22, Pages (November 2005)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 8, Issue 6, Pages (December 2010)
Volume 23, Issue 3, Pages (February 2013)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Ras Induces Mediator Complex Exchange on C/EBPβ
Robert L.S Perry, Maura H Parker, Michael A Rudnicki  Molecular Cell 
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Volume 93, Issue 5, Pages (May 1998)
Transcription Factor MIZ-1 Is Regulated via Microtubule Association
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 13, Issue 6, Pages (November 2015)
Volume 12, Issue 4, Pages (October 2003)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Halofuginone, an Inhibitor of Type-I Collagen Synthesis and Skin Sclerosis, Blocks Transforming-Growth-Factor-β-Mediated Smad3 Activation in Fibroblasts 
Melissa L. Ehlers, Barbara Celona, Brian L. Black  Cell Reports 
JNK Regulates Autocrine Expression of TGF-β1
Volume 19, Issue 5, Pages (November 2003)
c-Src Activates Endonuclease-Mediated mRNA Decay
ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes
Volume 61, Issue 6, Pages (June 2002)
Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy
Volume 9, Issue 3, Pages (March 2009)
Volume 2, Issue 1, Pages (July 1998)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 96, Issue 6, Pages (March 1999)
Volume 3, Issue 6, Pages (December 2002)
Volume 21, Issue 6, Pages (November 2017)
Joan E Durbin, Renée Hackenmiller, M.Celeste Simon, David E Levy  Cell 
Volume 10, Issue 4, Pages (April 1999)
Volume 57, Issue 2, Pages (October 2000)
Volume 125, Issue 4, Pages (May 2006)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 33, Issue 5, Pages (November 2010)
Volume 55, Issue 2, Pages (February 1999)
Mammalian SIRT1 Represses Forkhead Transcription Factors
Volume 107, Issue 7, Pages (December 2001)
In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets  Weiguo Zhai, Hyunkyung Jeong, Libin.
Volume 31, Issue 6, Pages (December 2009)
Volume 4, Issue 4, Pages (October 1999)
A Smad Transcriptional Corepressor
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Control of B Cell Production by the Adaptor Protein Lnk
Presentation transcript:

Negative Regulation of BMP/Smad Signaling by Tob in Osteoblasts Yutaka Yoshida, Sakae Tanaka, Hisashi Umemori, Osamu Minowa, Michihiko Usui, Naoko Ikematsu, Eri Hosoda, Takeshi Imamura, Junko Kuno, Teruhito Yamashita, Kohei Miyazono, Masaki Noda, Tetsuo Noda, Tadashi Yamamoto  Cell  Volume 103, Issue 7, Pages 1085-1097 (December 2000) DOI: 10.1016/S0092-8674(00)00211-7

Figure 1 Targeted Disruption of the tob Gene and Histological Analyses of Long Bones (A) Schematic illustration of the targeting vector, wild-type genomic DNA, and targeted locus of the tob gene. The coding region of the Tob protein is shown as a closed box. (B) The 3′ external probe (probe 1) was used for Southern blot analysis to detect homologous recombinants. Tail DNA from F1 progeny of two heterozygote intercrosses were digested with EcoRV and subjected to Southern blot hybridization. The genotype for the tob locus is indicated above each lane. Sizes of the DNA fragments are indicated on the left. (C) Protein lysates prepared from primary embryonic fibroblasts were analyzed by immunoblotting with the anti-Tob antibodies. (D) Plastic sections of tibiae from 9-month-old wild-type (left) and tob−/− mice (right) were stained with Villanueva Goldner. The upper panels show low-power views. The lower panels show high-power views. Scale bars in upper panels and lower panels indicate 0.5 mm and 0.1 mm, respectively. Cell 2000 103, 1085-1097DOI: (10.1016/S0092-8674(00)00211-7)

Figure 2 Static and Dynamic Histomorphometric Analyses and In Vivo Analyses of Bone Formation Histomorphometric markers of tob−/− mice of two different ages (4 months and 9 months) were analyzed. (A) Bone to tissue ratio (in volume) (BV/TV) reflects bone mass. (B–D) Osteoblast surface (ObS/BS) and osteoclast surface (OcS/BS) indicate the portion of bone surface covered by osteoblasts and osteoclasts, respectively. Eroded surface (ES/BS) represents the function of osteoclasts. (E) Bone formation rate was measured using sections double-labeled with calcein (see [F]). Open bars and closed bars represent wild-type and tob−/− mice, respectively. (F) Two calcein-labeled mineralization fronts of tibiae trabecular bone from 9-month-old wild-type (left) and tob−/− (right) mice were visualized by fluorescent micrography. Bars represent means ± SD. Asterisks indicate a statistically significant difference between wild-type and tob−/− mice (*p < 0.05, **p < 0.02, ***p < 0.01, n = 4). Statistical differences between groups were assessed by Student's t test. Cell 2000 103, 1085-1097DOI: (10.1016/S0092-8674(00)00211-7)

Figure 3 Expression of tob mRNA (A) Spatial expression of tob mRNA in bone rudiment. A section of the metatarsal bone prepared from a wild-type mouse embryo (d18.5) was analyzed by in situ hybridization using the antisense tob RNA probe. The upper panel shows a dark-field image, and the lower panel shows a bright-field image. The scale bar is 0.1 mm; arrowheads indicate the bone collar. (B) Expression of tob and tob2 mRNA in MC3T3 cells, osteoblast precursor cells, and osteoclasts as determined by Northern blot hybridization. (C) Northern blot of RNA from rhBMP2 (300 ng/ml)-stimulated 2T3 cells was probed by tob cDNA. (D) Northern blot of RNA isolated from BMP2-stimulated 2T3 cells cultured in the absence or presence of cychloheximide (CHX). The filter was probed by tob cDNA. CHX (20 μg/ml) was added 30 min before rhBMP2 (300 ng/ml) stimulation. Cell 2000 103, 1085-1097DOI: (10.1016/S0092-8674(00)00211-7)

Figure 4 Functional Analyses of Osteoblasts (A) Ex vivo culture of osteoblast lineage cells derived from calvariae of newborn wild-type or tob−/− mice. After cells were cultured for 3 weeks, they were fixed and then stained for ALP. (B) Effect of rhBMP-2 on the calvaria-derived cells. Calvaria-derived cells from newborn wild-type (open bars) or tob−/− (closed bars) mice were cultured for 7 days with various concentrations of rhBMP-2, and the ALP activity in cell extracts was measured. Bars represent means ± SD. Asterisks indicate a statistically significant difference between wild-type and tob−/− mice (*p < 0.05, **p < 0.03). Statistical differences between groups were assessed by Student's t test. (C) Expression of the ALP, osteocalcin, and tob mRNAs in calvaria-derived cells in the presence or absence of rhBMP2. Calvaria-derived cells from newborn wild-type or tob−/− mice were treated with rhBMP2 (300 ng/ml) for the indicated periods of time. (D) Effect of BMP2 (100 ng/ml) on [3H]thymidine incorporation in calvaria-derived cells. The cells in 0.5% FBS/α-MEM were treated with 100 ng/ml rhBMP2 and labeled with [3H]thymidine. Bars represent means ± SD. Asterisks indicate a statistically significant difference between wild-type and tob−/− mice (*p < 0.05, n = 4). Statistical differences between groups were assessed by Student's t test. Cell 2000 103, 1085-1097DOI: (10.1016/S0092-8674(00)00211-7)

Figure 5 In Vivo Stimulation of Bone Formation in Response to BMP2 (A) rhBMP2 (5 μg) was injected onto the center of the parietal bones of 3-day-old wild-type or tob−/− mice. Injection was carried out daily for 7 days, and animals were sacrificed two days after the last injection. X-ray pictures were then recorded. Arrows indicate newly formed bone. (B) Calvariae bone volume at the injection site (newly formed bone) was examined quantitatively with an image analyzer. Bars represent means ± SD. The difference in new bone formation in response to BMP2 between wild-type and in tob−/− mice was statistically significant (p < 0.05). Statistical difference between groups was assessed by Student's t test. Mean values for newly formed bone in wild-type mice was set to 1. Cell 2000 103, 1085-1097DOI: (10.1016/S0092-8674(00)00211-7)

Figure 6 Repression of Smad-Dependent Transcriptional Activation and Association of Tob with Smad Proteins (A and B) Repression of the BMP2-regulated promoter activity by Tob. C2C12 cells were transfected with the reporter construct, 4× SBE Luc (A), or 12× GCCG Luc (B) with Smad proteins and/or Tob expression plasmids. β-actin-β-gal plasmid was also cotransfected for normalization of transfection efficiency. After incubation for 24 hr in the presence or absence of 300 ng/ml rhBMP2, luciferase and β-galactosidase activities were determined. Mean luciferase activity of the cells transfected with the reporter plasmid alone and that received no BMP2 stimulation was set to 10. (C) The interactions of Flag-Tob with 6Myc-Smads in COS7 cells were examined by immunoprecipitation (IP) followed by immunoblotting (Blot). BMP-RIA(QD) and TβR-I(TD) are constitutively active forms of BMP type IA receptor and TGF-β type I receptor, respectively, and were tagged at the C terminus with the HA epitope. The top panel shows the interaction, the second panel from the top shows the Flag-Tob protein immunoprecipitated by the anti-Flag antibody, and the lower two panels show expression of each indicated protein. (D) Interaction of Tob with various Smad1 deletion mutants. FL, MH1, MH1 + L, L + MH2, and MH2 denote full-length, MH1 domain, MH1 domain + linker region, linker region + MH2 domain, and MH2 domain, respectively. The left panel shows the protein structures of wild-type Smad1 and various Smad1 deletion mutants. The right panel shows the interaction (upper panel) and expression of each indicated protein analyzed by blotting the lysates (middle panel) or the anti-Flag immunoprecipitates (lower panel). The efficiency of anti-FLAG immunoprecipitation (C and D) was similar between the lanes. Cell 2000 103, 1085-1097DOI: (10.1016/S0092-8674(00)00211-7)

Figure 7 Effect of Tob on the Subcellular Localization of Smad1 C2C12 cells were transfected with Flag-Smad1 alone or together with Myc-Tob and incubated either in the absence or presence of BMP2 for 3 hr. Flag-Smad1 was visualized with the anti-Flag antibody, and Tob was detected with the anti-Tob antibody. The cells were counterstained with TOTO-3 to identify nuclei. Cell 2000 103, 1085-1097DOI: (10.1016/S0092-8674(00)00211-7)